Transport characteristics of isorhamnetin across intestinal Caco-2 cell monolayers and the effects of transporters on it

Food and Chemical Toxicology

Volumn 66, Issue , 2014, Pages 313-320

  Duan, Jingze ^a   Xie, Yan ^a   Luo, Huilin ^a   Li, Guowen ^b   Wu, Tao ^a   Zhang, Tong ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Shanghai TCM Integrated Hospital   (China)

Author keywords

Absorption mechanism; Caco 2 cell; Isorhamnetin; Transport; Transporters

Indexed keywords

ADENOSINE TRIPHOSPHATE; BREAST CANCER RESISTANCE PROTEIN; EDETIC ACID; ESTRONE SULFATE; ISORHAMNETIN; MULTIDRUG RESISTANCE PROTEIN; ORGANIC ANION TRANSPORTER; VERLUKAST; 3-METHYLQUERCETIN; CARRIER PROTEIN; QUERCETIN;

ACTIVE TRANSPORT; ARTICLE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFUSION; DRUG ABSORPTION; DRUG CYTOTOXICITY; DRUG PENETRATION; DRUG POTENTIATION; DRUG STRUCTURE; DRUG TRANSPORT; PASSIVE TRANSPORT; PH; TEMPERATURE; TIGHT JUNCTION; TRANSPORT KINETICS; ANALOGS AND DERIVATIVES; CACO 2 CELL LINE; HUMAN; INTESTINE; METABOLISM;

CACO-2 CELLS; HUMANS; INTESTINES; MEMBRANE TRANSPORT PROTEINS; QUERCETIN; TEMPERATURE;

EID: 84896701820     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.02.003     Document Type: Article

References (58)

1. Ahn S.Y., Eraly S.A., Tsigelny I., Nigam S.K. Interaction of organic cations with organic anion transporters. J. Biol. Chem. 2009, 284:31422-31430.
2. Akao T., Hanada M., Sakashita Y., Sato K., Morita M., Imanaka T. Efflux of baicalin, a flavone glucuronide of Scutellariae Radix, on Caco-2 cells through multidrug resistance-associated protein 2. J. Pharm. Pharmacol. 2007, 59:87-93.
3. Bailey D.G., Arnold J.M., Munoz C., Spence J.D. Grapefruit juice-felodipine interaction: mechanism, predictability, and effect of naringin. Clin. Pharmacol. Ther. 1993, 53:637-642.
4. Barve A., Chen C., Hebbar V., Desiderio J., Saw C.L., Kong A.N. Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats. Biopharm. Drug Dispos. 2009, 30:356-365.
5. Brand W., van der Wel P.A., Rein M.J., Barron D., Williamson G., van Bladeren P.J., Rietjens I.M. Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers. Drug Metab. Dispos. 2008, 36:1794-1802.
6. Buyukozturk F., Benneyan J.C., Carrier R.L. Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics. J. Control. Release 2010, 142:22-30.
7. Cao J., Chen X., Liang J., Yu X.Q., Xu A.L., Chan E., Wei D., Huang M., Wen J.Y., Yu X.Y., Li X.T., Sheu F.S., Zhou S.F. Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra. Drug Metab. Dispos. 2007, 35:539-553.
8. Chen J., Lin H., Hu M. Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model. Cancer Chemother. Pharmacol. 2005, 55:159-169.
9. Chi J.D., He X.F., Liu A.R., Xu L.X. HPLC determination of six flavonoid constituents in Ginkgo biloba leaves. Yao Xue Xue Bao 1997, 32:625-628.
10. Citi S. Protein kinase inhibitors prevent junction dissociation induced by low extracellular calcium in MDCK epithelial cells. J. Cell Biol. 1992, 117:169-178.
11. Cornish K.M., Williamson G., Sanderson J. Quercetin metabolism in the lens: role in inhibition of hydrogen peroxide induced cataract. Free Radic. Biol. Med. 2002, 33:63-70.
12. Crowe A., Diep S. PH dependent efflux of methamphetamine derivatives and their reversal through human Caco-2 cell monolayers. Eur. J. Pharmacol. 2008, 592:7-12.
13. Dragoni S., Gee J., Bennett R., Valoti M., Sgaragli G. Red wine alcohol promotes quercetin absorption and directs its metabolism towards isorhamnetin and tamarixetin in rat intestine in vitro. Br. J. Pharmacol. 2006, 147:765-771.
14. Estudante M., Morais J.G., Soveral G., Benet L.Z. Intestinal drug transporters: an overview. Adv. Drug Deliv. Rev. 2012, doi: 10.1016/j.addr.2012.09.042.
15. Gao Y., Wang Y.Q., Ma Y.K., Yu A.H., Cai F.Q., Shao W., Zhai G.X. Formulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsion. Colloids Surf. B Biointerfaces 2009, 71:306-314.
16. Han Y.H., Busler D., Hong Y., Tian Y.A., Chen C., Rodrigues A.D. Transporter studies with the 3-O-sulfate conjugate of 17 alpha-ethinylestradiol: assessment of human kidney drug transporters. Drug Metab. Dispos. 2010, 38:1064-1071.
17. Hilgendorf C., Ahlin G., Seithel A., Artursson P., Ungell A.L., Karlsson J. Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab. Dispos. 2007, 35:1333-1340.
18. Hong J., Lambert J.D., Lee S.H., Sinko P.J., Yang C.S. Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochem. Biophys. Res. Commun. 2003, 310:222-227.
19. Hovgaard L., Brondsted H., Buur A., Bundgaard H. Drug delivery studies in Caco-2 monolayers. Synthesis, hydrolysis, and transport of O-cyclopropane carboxylic acid ester prodrugs of various beta-blocking agents. Pharm. Res. 1995, 12:387-392.
20. Hubatsch I., Ragnarsson E.G.E., Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat. Protoc. 2007, 2:2111-2119.
21. Khaled K.A., El-Sayed Y.M., Al-Hadiya B.M. Disposition of the flavonoid quercetin in rats after single intravenous and oral doses. Drug Dev. Ind. Pharm. 2003, 29:397-403.
22. Kim J.E., Lee D.E., Lee K.W., Son J.E., Seo S.K., Li J., Jung S.K., Heo Y.S., Mottamal M., Bode A.M., Dong Z., Lee H.J. Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3-K. Cancer Prev. Res. (Phila) 2011, 4:582-591.
23. Kobayashi S., Tanabe S., Sugiyama M., Konishi Y. Transepithelial transport of hesperetin and hesperidin in intestinal Caco-2 cell monolayers. Biochim. Biophys. Acta 2008, 1778:33-41.
24. Kowapradit J., Opanasopit P., Ngawhirunpat T., Rojanarata T., Ruktanonchai U., Sajomsang W. Methylated N-(4-N,N-dimethylaminocinnamyl) chitosan enhances paracellular permeability across Caco-2 cells. Drug Deliv. 2010, 17:301-312.
25. Krishna G., Chen K.W.J., Lin C.C., Nomeir A.A. Permeability of lipophilic compounds in drug discovery using in vitro human absorption model, Caco-2. Int. J. Pharm. 2001, 222:77-89.
26. Kumar M.S.Y., Dutta R., Prasad D., Misra K. Subcritical water extraction of antioxidant compounds from Seabuckthorn (Hippophae rhamnoides) leaves for the comparative evaluation of antioxidant activity. Food Chem. 2011, 127:1309-1316.
27. Kuwayama K., Inoue H., Kanamori T., Tsujikawa K., Miyaguchi H., Iwata Y., Miyauchi S., Kamo N., Kishi T. Uptake of 3,4-methylenedioxymethamphetamine and its related compounds by a proton-coupled transport system in Caco-2 cells. Biochim. Biophys. Acta 2008, 1778:42-50.
28. Lan K., He J.L., Tian Y., Tan F., Jiang X.H., Wang L., Ye L.M. Intra-herb pharmacokinetics interaction between quercetin and isorhamentin. Acta Pharmacol. Sin. 2008, 29:1376-1382.
29. Lee J., Jung E., Lee J., Kim S., Huh S., Kim Y., Kim Y., Byun S.Y., Kim Y.S., Park D. Isorhamnetin represses adipogenesis in 3T3-L1 cells. Obesity 2009, 17:226-232.
30. Li C., Zhang L., Zhou L., Wo S.K., Lin G., Zuo Z. Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix scutellariae. AAPS J. 2012, 14:23-34.
31. Li G., Zeng X., Xie Y., Cai Z., Moore J.C., Yuan X., Cheng Z., Ji G. Pharmacokinetic properties of isorhamnetin, kaempferol and quercetin after oral gavage of total flavones of Hippophae rhamnoides L. in rats using a UPLC-MS method. Fitoterapia 2012, 83:182-191.
32. Liang E., Chessic K., Yazdanian M. Evaluation of an accelerated Caco-2 cell permeability model. J. Pharm. Sci. 2000, 89:336-345.
33. Maubon N., Le Vee M., Fossati L., Audry M., Le Ferrec E., Bolze S., Fardel O. Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR. Fundam. Clin. Pharmacol. 2007, 21:659-663.
34. Menez C., Buyse M., Dugave C., Farinotti R., Barratt G. Intestinal absorption of miltefosine: contribution of passive paracellular transport. Pharm. Res. 2007, 24:546-554.
35. Meunier V., Bourrie M., Berger Y., Fabre G. The human intestinal epithelial-cell line Caco-2 - pharmacological and pharmacokinetic applications. Cell Biol. Toxicol. 1995, 11:187-194.
36. Muller W.E., Heiser J., Leuner K. Effects of the standardized Ginkgo biloba extract EGb 761 (R) on neuroplasticity. Int. Psychogeriatr. 2012, Suppl. 24:S21-S24.
37. Nait Chabane M., Al Ahmad A., Peluso J., Muller C.D., Ubeaud G. Quercetin and naringenin transport across human intestinal Caco-2 cells. J. Pharm. Pharmacol. 2009, 61:1473-1483.
38. Prime-Chapman H.M., Fearn R.A., Cooper A.E., Moore V., Hirst B.H. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells. J. Pharmacol. Exp. Ther. 2004, 311:476-484.
39. Rajnarayana K., Reddy M.S., Vidyasagar J., Krishna D.R. Study on the influence of silymarin pretreatment on metabolism and disposition of metronidazole. Arzneimittel-Forschung 2004, 54:109-113.
40. Rocha R.A., Devesa V., Velez D. In vitro study of intestinal transport of fluoride using the Caco-2 cell line. Food Chem. Toxicol. 2013, 55:156-163.
41. Seithel A., Karlsson J., Hilgendorf C., Bjorquist A., Ungell A.L. Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells. Eur. J. Pharm. Sci. 2006, 28:291-299.
42. Sesink A.L., Arts I.C., de Boer V.C., Breedveld P., Schellens J.H., Hollman P.C., Russel F.G. Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides. Mol. Pharmacol. 2005, 67:1999-2006.
43. Spyridopoulos T.N., Petridou E.T., Dessypris N., Terzidis A., Skalkidou A., Deliveliotis C., Chrousos G.P., Grp O.C.O. Inverse association of leptin levels with renal cell carcinoma: results from a case-control study. Hormones (Athens) 2009, 8:39-46.
44. Taipalensuu J., Tornblom H., Lindberg G., Einarsson C., Sjoqvist F., Melhus H., Garberg P., Sjostrom B., Lundgren B., Artursson P. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J. Pharmacol. Exp. Ther. 2001, 299:164-170.
45. Tian X.J., Yang X.W., Yang X., Wang K. Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model. Int. J. Pharm. 2009, 367:58-64.
46. Tourniaire F., Hassan M., Andre M., Ghiringhelli O., Alquier C., Amiot M.J. Molecular mechanisms of the naringin low uptake by intestinal Caco-2 cells. Mol. Nutr. Food Res. 2005, 49:957-962.
47. Troutman M.D., Thakker D.R. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium. Pharm. Res. 2003, 20:1210-1224.
48. Ursic D., Berginc K., Zakelj S., Kristl A. Influence of luminal monosaccharides on secretion of glutathione conjugates from rat small intestine in vitro. Int. J. Pharm. 2009, 381:199-204.
49. Vaidyanathan J.B., Walle T. Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2. J. Pharmacol. Exp. Ther. 2003, 307:745-752.
50. van Dijk C., Driessen A.J., Recourt K. The uncoupling efficiency and affinity of flavonoids for vesicles. Biochem. Pharmacol. 2000, 60:1593-1600.
51. Walgren R.A., Karnaky K.J., Lindenmayer G.E., Walle T. Efflux of dietary flavonoid quercetin 4'-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J. Pharmacol. Exp. Ther. 2000, 294:830-836.
52. Wang Y., Cao J., Zeng S. Involvement of P-glcoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin. J. Pharm. Pharmacol. 2005, 57:751-758.
53. Wong C.C., Akiyama Y., Abe T., Lippiat J.D., Orfila C., Williamson G. Carrier-mediated transport of quercetin conjugates: involvement of organic anion transporters and organic anion transporting polypeptides. Biochem. Pharmacol. 2012, 84:564-570.
54. Yang C.H., Glover K.P., Han X. Characterization of cellular uptake of perfluorooctanoate via organic anion-transporting polypeptide 1A2, organic anion transporter 4, and urate transporter 1 for their potential roles in mediating human renal reabsorption of perfluorocarboxylates. Toxicol. Sci. 2010, 117:294-302.
55. Zhang S., Yang X., Morris M.E. Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport. Pharm. Res. 2004, 21:1263-1273.
56. Zhang L., Lin G., Kovacs B., Jani M., Krajcsi P., Zuo Z. Mechanistic study on the intestinal absorption and disposition of baicalein. Eur. J. Pharm. Sci. 2007, 31:221-231.
57. Zhang N., Pei F., Wei H., Zhang T., Yang C., Ma G. Isorhamnetin protects rat ventricular myocytes from ischemia and reperfusion injury. Exp. Toxicol. Pathol. 2011, 63:33-38.
58. Zhao G., Duan J., Xie Y., Lin G., Luo H., Li G., Yuan X. Effects of solid dispersion and self-emulsifying formulations on the solubility, dissolution, permeability and pharmacokinetics of isorhamnetin, quercetin and kaempferol in total flavones of Hippophae rhamnoides L. Drug Dev. Ind. Pharm. 2013, 39:1037-1045.